‘Patent dance’ ruling leaves lawyers in a spin

23-07-2015

‘Patent dance’ ruling leaves lawyers in a spin

Rob Marmion / Shutterstock.com

The US Court of Appeals for the Federal Circuit’s decision in Amgen v Sandoz is what the biosimilar industry would have been hoping for but clarity is lacking in several areas, lawyers have told LSIPR.


Sandoz, Amgen, Zarxio, Neupogen, biosimilar, BPCIA, patent dance

LSIPR